Comparison of the chronic cellular, molecular, and clinical pathophysiological changes after single and repetitive TBI

Pathophysiological chronic changes
Both single and repetitive brain trauma lead to development of long-term neurological disorders [33, 35, 36, 39, 80, 81], depending on the extent of the acute injury
Single TBI (sTBI)
Cellular Molecular Clinical
Glial scaring [91]
Hyperactivated microglia [77, 125, 126]
Accumulation of β-amyloid plaques [142-145], mostly in grey and less in white brain matter [142], predominantly with fibrillar characteristics (such as seen in developed Alzheimer's disease) [137, 146] and possible genetic predisposition risk [142, 147]
Neurofibrillary tangles (NFT) with a distribution that matches the one in Alzheimer's disease [141, 148]
Accumulation of α-synuclein in some patients [149, 150]
Loss of synapses and progressive neuronal deficit [142, 151]
TDP-43 proteinopathy? [56, 152, 153]
Generalized brain atrophy [137, 154, 155] includes entire brain parenchyma (including the frontal), grey and white matter of the cerebrum, cerebellum, and brainstem [155] with volume reduction of corpus callosum [58, 156]
Cognitive disorders [157] depending on the degree of degenerated anatomical structures [158]
Increased Alzheimer’s disease risk [136, 159, 160]
Repetitive TBI (rTBI)
Cellular Molecular Clinical
Tau deposits in astrocytes and neurons [161, 162]
Hyperactivated microglia [77]
Hyperphosphorylated tau protein aggregates (NFTs) in the cortical sulci, perivascular regions of the frontal lobe, midbrain, thalamus, basal ganglia, amygdala and hippocampus [137, 163]
Beta-amyloid aggregates and Lewi’s bodies present in some patients [137, 164]
TDP-43 proteinopathy [152, 154, 164-166]
Localized brain atrophy detected in the frontal and temporal part of the cortex and the cerebellum [137, 167]; atrophy of the hippocampus and amygdala and entorhinal cortex [40, 138, 168, 169]
Enlargement of the cavum septum pellucidum [40, 170, 171], with occasional absence of the septum or its separation from the fornix and the corpus callosum [40, 137, 171-176]
Cognitive dysfunction [168, 169, 177] with pyramidal, extrapyramidal, and cerebellar dysfunction observed [137]
Increased CTE risk development [164]
Exp Neurobiol 2023;32:195~215 https://doi.org/10.5607/en23008
© Exp Neurobiol